PURPOSE: This study seeks to establish the construct validity of Health Utilities Index Mark 3 (HUI3)--a health state utility measure--in a Nigerian population of hypertensive patients. METHODS: A descriptive cross-sectional study was conducted in a population of hypertensive patients in two tertiary hospitals located in South-Eastern Nigeria. A priori hypotheses were tested to establish construct validity. RESULTS: A total of 384 participants were interviewed. Hypertensive patients with stroke or coronary heart disease (CHD) had a lower overall utility value compared to those with hypertension alone. There was a significant difference in group means of 0.53 (95 % confidence interval of 0.44-0.62); t = 11.8, p < 0.01, between participants that had hypertension alone and participants with hypertension and stroke. Also, there was a significant difference in group means of 0.44 (95 % confidence interval of 0.34-0.56); t = 8.2, p < 0.01, between participants that had hypertension alone and participants with hypertension and CHD. Generally, there was a significant health-related quality of life deficit among patients with severe clinical variables compared to those with milder clinical variables. CONCLUSION: HUI3 demonstrated constructed validity among a population of Nigerian patients with high blood pressure.
PURPOSE: This study seeks to establish the construct validity of Health Utilities Index Mark 3 (HUI3)--a health state utility measure--in a Nigerian population of hypertensivepatients. METHODS: A descriptive cross-sectional study was conducted in a population of hypertensivepatients in two tertiary hospitals located in South-Eastern Nigeria. A priori hypotheses were tested to establish construct validity. RESULTS: A total of 384 participants were interviewed. Hypertensivepatients with stroke or coronary heart disease (CHD) had a lower overall utility value compared to those with hypertension alone. There was a significant difference in group means of 0.53 (95 % confidence interval of 0.44-0.62); t = 11.8, p < 0.01, between participants that had hypertension alone and participants with hypertension and stroke. Also, there was a significant difference in group means of 0.44 (95 % confidence interval of 0.34-0.56); t = 8.2, p < 0.01, between participants that had hypertension alone and participants with hypertension and CHD. Generally, there was a significant health-related quality of life deficit among patients with severe clinical variables compared to those with milder clinical variables. CONCLUSION: HUI3 demonstrated constructed validity among a population of Nigerian patients with high blood pressure.
Authors: Jipan Xie; Eric Q Wu; Zhi-Jie Zheng; Janet B Croft; Kurt J Greenlund; George A Mensah; Darwin R Labarthe Journal: Stroke Date: 2006-08-31 Impact factor: 7.914
Authors: David Feeny; Karen Farris; Isabelle Côté; Jeffrey A Johnson; Ross T Tsuyuki; Ken Eng Journal: J Clin Epidemiol Date: 2005-02 Impact factor: 6.437
Authors: Sheri L Maddigan; David H Feeny; Sumit R Majumdar; Karen B Farris; Jeffrey A Johnson Journal: J Clin Epidemiol Date: 2006-03-14 Impact factor: 6.437
Authors: David Feeny; William Furlong; George W Torrance; Charles H Goldsmith; Zenglong Zhu; Sonja DePauw; Margaret Denton; Michael Boyle Journal: Med Care Date: 2002-02 Impact factor: 2.983
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272